Gem Aromatics reports Q1FY27 standalone revenue growth of 9% YoY. Strategy focuses on scaling the new Dahej facility and expanding into higher-value specialty molecules like cooling agents and phenol derivatives.
Gem Aromatics reports Q4 FY26 sequential recovery with consolidated revenue of ₹110cr (up 40% QoQ). Strategy focuses on diversifying from mint into high-margin clove derivatives and cooling agents via the new Dahej facility.
Gem Aromatics reports sequential recovery in Q4FY26 with revenue of ₹110 Cr (Consolidated). Focus is on ramp-up at the greenfield Dahej facility and higher-value specialty molecules.